Year |
Citation |
Score |
2019 |
Johnson-Davis KL, Doyle K. Therapeutic Drug Monitoring in Pregnant Patients. Therapeutic Drug Monitoring. PMID 31609886 DOI: 10.1097/Ftd.0000000000000709 |
0.304 |
|
2019 |
Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, ... ... Johnson-Davis KL, et al. Therapeutic drug monitoring of tacrolimus-personalized therapy: Second consensus report. Therapeutic Drug Monitoring. PMID 31045868 DOI: 10.1097/Ftd.0000000000000640 |
0.327 |
|
2019 |
Merrigan S, Johnson-Davis KL. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method to Quantify Gabapentin and Pregabalin in Urine. Methods in Molecular Biology (Clifton, N.J.). 1872: 119-127. PMID 30350285 DOI: 10.1007/978-1-4939-8823-5_12 |
0.376 |
|
2019 |
Rule GS, Rockwood AL, Johnson-Davis KL. LC-MS/MS Method for the Quantification of the Leflunomide Metabolite, Teriflunomide, in Human Serum/Plasma. Methods in Molecular Biology (Clifton, N.J.). 1872: 75-83. PMID 30350281 DOI: 10.1007/978-1-4939-8823-5_8 |
0.396 |
|
2019 |
Calvaresi E, Wyness S, Jackson A, Genzen J, Johnson-Davis K. Assessing Propylene Glycol Interference at Concentrations Relevant to Serum Levels With Electronic Cigarette Use in an Enzymatic Ethylene Glycol Assay American Journal of Clinical Pathology. 152: S26-S27. DOI: 10.1093/Ajcp/Aqz112.051 |
0.305 |
|
2017 |
Wu F, Slawson MH, Johnson-Davis KL. Metabolic Patterns of Fentanyl, Meperidine, Methylphenidate, Tapentadol and Tramadol Observed in Urine, Serum or Plasma. Journal of Analytical Toxicology. PMID 28119437 DOI: 10.1093/Jat/Bkx003 |
0.341 |
|
2017 |
Johnson-Davis KL. Opiate & Benzodiazepine Confirmations: To Hydrolyze or Not to Hydrolyze is the Question The Journal of Applied Laboratory Medicine: An Aacc Publication. 2: 564-572. DOI: 10.1373/Jalm.2016.022947 |
0.359 |
|
2017 |
Merrigan SD, Kish-Trier E, Seegmiller JC, Johnson-Davis KL. LC–MS/MS method for quantitation of mycophenolic acid, mycophenolic acid acyl-glucuronide, and 7-O-mycophenolic acid glucuronide in serum Clinical Mass Spectrometry. 3: 41-48. DOI: 10.1016/J.Clinms.2017.07.001 |
0.355 |
|
2016 |
Yang HS, Wu AH, Johnson-Davis KL, Lynch KL. Development and validation of an LC-MS/MS sulfonylurea assay for hypoglycemia cases in the emergency department. Clinica Chimica Acta; International Journal of Clinical Chemistry. 454: 130-134. PMID 26790752 DOI: 10.1016/J.Cca.2016.01.007 |
0.333 |
|
2016 |
Rule GS, Rockwood AL, Johnson-Davis KL. Quantitation of Teriflunomide in Human Serum/Plasma Across a 40,000-Fold Concentration Range by LC/MS/MS. Methods in Molecular Biology (Clifton, N.J.). 1383: 195-203. PMID 26660188 DOI: 10.1007/978-1-4939-3252-8_21 |
0.389 |
|
2016 |
Slawson MH, Johnson-Davis KL. Quantitation of Ethyl Glucuronide and Ethyl Sulfate in Urine Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods in Molecular Biology (Clifton, N.J.). 1383: 167-75. PMID 26660185 DOI: 10.1007/978-1-4939-3252-8_18 |
0.353 |
|
2016 |
Slawson MH, Johnson-Davis KL. Quantitation of Carisoprodol and Meprobamate in Urine and Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods in Molecular Biology (Clifton, N.J.). 1383: 105-14. PMID 26660179 DOI: 10.1007/978-1-4939-3252-8_12 |
0.381 |
|
2016 |
Slawson MH, Johnson-Davis KL. Quantitation of Haloperidol, Fluphenazine, Perphenazine, and Thiothixene in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods in Molecular Biology (Clifton, N.J.). 1383: 49-57. PMID 26660173 DOI: 10.1007/978-1-4939-3252-8_6 |
0.391 |
|
2016 |
Slawson MH, Johnson-Davis KL. Quantitation of Flecainide, Mexiletine, Propafenone, and Amiodarone in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods in Molecular Biology (Clifton, N.J.). 1383: 11-9. PMID 26660169 DOI: 10.1007/978-1-4939-3252-8_2 |
0.385 |
|
2015 |
Johnson-Davis KL, Sadler AJ, Genzen JR. A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory. Journal of Analytical Toxicology. PMID 26668238 DOI: 10.1093/Jat/Bkv133 |
0.358 |
|
2015 |
Schniedewind B, Niederlechner S, Galinkin JL, Johnson-Davis KL, Christians U, Meyer EJ. Long-term cross-validation of everolimus therapeutic drug monitoring assays: the Zortracker study. Therapeutic Drug Monitoring. 37: 296-303. PMID 25970506 DOI: 10.1097/Ftd.0000000000000191 |
0.312 |
|
2015 |
McMillin GA, Marin SJ, Johnson-Davis KL, Lawlor BG, Strathmann FG. A hybrid approach to urine drug testing using high-resolution mass spectrometry and select immunoassays. American Journal of Clinical Pathology. 143: 234-40. PMID 25596249 DOI: 10.1309/Ajcpmjkbc6Vja1Sp |
0.338 |
|
2015 |
Rule GS, Rockwood AL, Johnson-Davis KL. LC-MS/MS Method for Determination of Teriflunomide, Over a 40,000-Fold Dynamic Range Using Overlapping Calibrators. Therapeutic Drug Monitoring. 37: 472-8. PMID 25525756 DOI: 10.1097/Ftd.0000000000000166 |
0.374 |
|
2015 |
Marin SJ, Sawyer JC, He X, Johnson-Davis KL. Comparison of drug detection by three quadrupole time-of-flight mass spectrometry platforms. Journal of Analytical Toxicology. 39: 89-95. PMID 25505058 DOI: 10.1093/Jat/Bku134 |
0.362 |
|
2015 |
Signorelli H, Lehman C, Johnson-Davis KL. 33: NicAlert Performance Compared to Liquid Chromatography-Tandem Mass Spectrometry and Immunoassay American Journal of Clinical Pathology. 143: A017-A017. DOI: 10.1093/Ajcp/143.Suppl1.018 |
0.316 |
|
2014 |
Lin CN, Juenke JM, Johnson-Davis KL. Method validation of a tricyclic antidepressant drug panel in urine by UPLC-MS/MS. Annals of Clinical and Laboratory Science. 44: 431-6. PMID 25361928 |
0.3 |
|
2014 |
Petrides AK, Moskowitz J, Johnson-Davis KL, Jannetto PJ, Langman LJ, Clarke W, Marzinke MA. The development and validation of a turbulent flow-liquid chromatography-tandem mass spectrometric method for the simultaneous quantification of citalopram, sertraline, bupropion and hydroxybupropion in serum. Clinical Biochemistry. 47: 73-9. PMID 25087976 DOI: 10.1016/J.Clinbiochem.2014.07.018 |
0.39 |
|
2013 |
McMillin GA, Slawson MH, Marin SJ, Johnson-Davis KL. Demystifying analytical approaches for urine drug testing to evaluate medication adherence in chronic pain management. Journal of Pain & Palliative Care Pharmacotherapy. 27: 322-39. PMID 24147959 DOI: 10.3109/15360288.2013.847889 |
0.327 |
|
2013 |
Juenke JM, Brown PI, Urry FM, Johnson-Davis KL, McMillin GA. Simultaneous UPLC-MS/MS assay for the detection of the traditional antipsychotics haloperidol, fluphenazine, perphenazine, and thiothixene in serum and plasma. Clinica Chimica Acta; International Journal of Clinical Chemistry. 423: 32-4. PMID 23618971 DOI: 10.1016/J.Cca.2013.04.014 |
0.379 |
|
2012 |
Johnson-Davis KL, Juenke JM, Davis R, McMillin GA. Quantification of tricyclic antidepressants using UPLC-MS/MS. Methods in Molecular Biology (Clifton, N.J.). 902: 175-84. PMID 22767118 DOI: 10.1007/978-1-61779-934-1_16 |
0.399 |
|
2012 |
Johnson-Davis KL, Thompson CD, Clark CJ, McMillin GA, Lehman CM. Method comparison of the Ortho Vitros Fusion 5,1 chemistry analyzer and the Roche COBAS Integra 400 for urine drug screen testing in the emergency department. Journal of Analytical Toxicology. 36: 345-8. PMID 22582270 DOI: 10.1093/Jat/Bks028 |
0.351 |
|
2012 |
McMillin GA, Johnson-Davis K, Dasgupta A. Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood. Therapeutic Drug Monitoring. 34: 222-6. PMID 22322402 DOI: 10.1097/Ftd.0B013E318246D515 |
0.36 |
|
2012 |
Juenke JM, McGraw JP, McMillin GA, Johnson-Davis KL. Performance characteristics and patient comparison of the ARK Diagnostics levetiracetam immunoassay with an ultra-high performance liquid chromatography with tandem mass spectrometry detection method. Clinica Chimica Acta; International Journal of Clinical Chemistry. 413: 529-31. PMID 22137980 DOI: 10.1016/J.Cca.2011.11.018 |
0.318 |
|
2011 |
Rockwood AL, Johnson-Davis KL. Mass spectrometry for clinical toxicology: therapeutic drug management and trace element analysis. Clinics in Laboratory Medicine. 31: 407-28. PMID 21907106 DOI: 10.1016/J.Cll.2011.07.003 |
0.309 |
|
2011 |
Johnson-Davis KL, De S, Jimenez E, McMillin GA, De BK. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method. Therapeutic Drug Monitoring. 33: 453-9. PMID 21743377 DOI: 10.1097/Ftd.0B013E3182263981 |
0.403 |
|
2011 |
Juenke JM, Miller KA, Ford MA, McMillin GA, Johnson-Davis KL. A comparison of two FDA approved lamotrigine immunoassays with ultra-high performance liquid chromatography tandem mass spectrometry. Clinica Chimica Acta; International Journal of Clinical Chemistry. 412: 1879-82. PMID 21693111 DOI: 10.1016/J.Cca.2011.06.009 |
0.367 |
|
2011 |
Juenke JM, Wienhoff KA, Anderson BL, McMillin GA, Johnson-Davis KL. Performance characteristics of the ARK diagnostics gabapentin immunoassay. Therapeutic Drug Monitoring. 33: 398-401. PMID 21654348 DOI: 10.1097/Ftd.0B013E318220Bb65 |
0.321 |
|
2011 |
Juenke JM, Miller KA, McMillin GA, Johnson-Davis KL. An automated method for supporting busulfan therapeutic drug monitoring. Therapeutic Drug Monitoring. 33: 315-20. PMID 21544019 DOI: 10.1097/Ftd.0B013E318214Cd75 |
0.347 |
|
2011 |
Juenke JM, Brown PI, Johnson-Davis KL, McMillin GA. Simultaneous quantification of levetiracetam and gabapentin in plasma by ultra-pressure liquid chromatography coupled with tandem mass spectrometry detection. Therapeutic Drug Monitoring. 33: 209-13. PMID 21297550 DOI: 10.1097/Ftd.0B013E31820B1Fce |
0.321 |
|
2010 |
Johnson-Davis KL, McMillin GA, Juenke JM, Ford CD, Petersen FB. Which dose of busulfan is best? Clinical Chemistry. 56: 1061-4. PMID 20585045 DOI: 10.1373/Clinchem.2009.134940 |
0.35 |
|
2007 |
Danaceau JP, Deering CE, Day JE, Smeal SJ, Johnson-Davis KL, Fleckenstein AE, Wilkins DG. Persistence of tolerance to methamphetamine-induced monoamine deficits. European Journal of Pharmacology. 559: 46-54. PMID 17239369 DOI: 10.1016/J.Ejphar.2006.11.045 |
0.602 |
|
2005 |
Rau KS, Birdsall E, Hanson JE, Johnson-Davis KL, Carroll FI, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE. Bupropion increases striatal vesicular monoamine transport. Neuropharmacology. 49: 820-30. PMID 16005476 DOI: 10.1016/J.Neuropharm.2005.05.004 |
0.582 |
|
2005 |
Truong JG, Wilkins DG, Baudys J, Crouch DJ, Johnson-Davis KL, Gibb JW, Hanson GR, Fleckenstein AE. Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity. The Journal of Pharmacology and Experimental Therapeutics. 314: 1087-92. PMID 15901804 DOI: 10.1124/Jpet.105.085951 |
0.593 |
|
2004 |
Johnson-Davis KL, Truong JG, Fleckenstein AE, Wilkins DG. Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine. The Journal of Pharmacology and Experimental Therapeutics. 309: 578-86. PMID 14747615 DOI: 10.1124/Jpet.103.062695 |
0.6 |
|
2003 |
Johnson-Davis KL, Fleckenstein AE, Wilkins DG. The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity. European Journal of Pharmacology. 482: 151-4. PMID 14660016 DOI: 10.1016/J.Ejphar.2003.09.063 |
0.611 |
|
2003 |
Johnson-Davis KL, Hanson GR, Keefe KA. Lack of effect of kappa-opioid receptor agonism on long-term methamphetamine-induced neurotoxicity in rats. Neurotoxicity Research. 5: 273-81. PMID 12835119 DOI: 10.1007/Bf03033385 |
0.353 |
|
2002 |
Johnson-Davis KL, Hanson GR, Keefe KA. Long-term post-synaptic consequences of methamphetamine on preprotachykinin mRNA expression. Journal of Neurochemistry. 82: 1472-9. PMID 12354295 DOI: 10.1046/J.1471-4159.2002.01095.X |
0.329 |
|
Show low-probability matches. |